2. FDA approves first immunotherapy for initial treatment of gastric cancer. News release. FDA. April 16, 2021. Accessed September 19, 2021. <https://bit.ly/3tqsjKA> 3. Moehler M. Shitara K, Garrido M, et al. ...
参考文献: [1]Janjigian Y Y, Shitara K, Moehler M, et al. First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomi...
1.Checkmate郑容和林俊杰合唱歌曲 2.《Checkmate》收录在郑容和solo专辑《One Fine Day》及林俊杰第11张个人专辑《新地球GENESIS》（内地版）中，由郑容和、李祥浩编曲，郑容和作曲，林俊杰、郑容和作词并演唱 。3.No way no way 이 주위엔 칼과 &#...
[10] HellmannMD, Chaft JE, William WN Jr, et al. Pathological response after neoadjuvant chemotherapy in resectable non-small-cell lung cancers: proposal for the use of major pathological response as a surrogate endpoint. Lancet Oncol 2014;15:e42-e50. [11] Liang W, Cai K, Chen C, et al...
[2]Brastianos, P.K., Strickland, M.R., Lee, E.Q. et al. Phase II study of ipilimumab and nivolumab in leptomeningeal carcinomatosis. Nat Commun 12, 5954 (2021). https://www.nature.com/articles/s41467-021-25859-y [3] Halle BR, Betof Warner A, Zaman FY, et al Immune checkpoint...
adobe68k) basic_machine=m68010-adobe os=-scout ;; alliant | fx80) basic_machine=fx80-alliant ;; altos | altos3068) basic_machine=m68k-altos ;; am29k) basic_machine=a29k-none os=-bsd ;; amd64) basic_machine=x86_64-pc ;; amd64-*) basic_machine=x86_...
[76]. One study found that patients with KRAS mutations treated with ICI therapy within 90 days of NSCLC BrM diagnosis, of whom 97% were initially treated with SRS, had improved OS compared to those that didn’t have KRAS mutations and were treated with ICI therapy. However, patients who ...
雪上小王子 逐浪的玫瑰 潘塔龙 多加雷萨 壁画修复员 不羁的浪漫 胡桃夹子 浴石商人 收藏品 苗木诚 罪木蜜柑 雾切响子 王马小吉 天海兰太郎 毛利兰 安室透 反光镜 公路骑士 助燃剂 宋杰 冬 报纸怪客 放映厅 滚滚伙伴 广津柳浪 樋口一叶 江户川乱步 异星开采 生态圈 迫降专家 线控信号 Lady K 葛雷 凯瑟琳...
Checkmate 76K–adjuvant treatment of patients 12 years of age and older with completely resected Stage IIB or Stage IIC melanoma; Checkmate 274–adjuvant treatment of urothelial carcinoma; Checkmate 275–previously treated advanced or metastatic urothelial carcinoma; Checkmate 142–MSI-H o...
2022 年,发表于 New England Journal of Medicine 的 CheckMate-816 研究[1]的结果证实,相较于单纯化疗,新辅助纳武利尤单抗联合化疗可显著改善可切除非小细胞肺癌(NSCLC)患者的无事件生存期(EFS)率和病理学完全缓解(pCR)率。基于这一重要发现,纳武利尤单抗联合含铂双药化疗已经获得美国食品药品监督管理局(FDA)以及...